Literature DB >> 8013720

Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens.

A D Dick1, Y F Cheng, J Liversidge, J V Forrester.   

Abstract

Experimental autoimmune uveoretinitis (EAU) is a CD4+ T-lymphocyte mediated inflammation of the uveal tract and retina. As a model of human posterior uveitis it permits further understanding of the underlying immunopathogenesis of uveitis. It also allows for preclinical trials of immunosuppressive therapies and in vivo assessment of alternative strategies for immunointervention. This review highlights possible immunostrategic modalities which prevent the initiation or perpetuation of the immune response, and in particular reports on the novel effect of intranasal induction of tolerance with retinal antigens, prior to immunisation with retinal antigens. The mechanisms and potential application of this 'natural' method of immunosuppression in the treatment of autoimmune disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013720     DOI: 10.1038/eye.1994.10

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  22 in total

1.  Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.

Authors:  B Laliotou; J Liversidge; J V Forrester; A D Dick
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

2.  Enhanced tolerance to autoimmune uveitis in CD200-deficient mice correlates with a pronounced Th2 switch in response to antigen challenge.

Authors:  Neil Taylor; Karen McConachie; Karen McConnachie; Claudia Calder; Rosemary Dawson; Andrew Dick; Jonathon D Sedgwick; Janet Liversidge
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

3.  Uveitogenic epitopes of retinal S-antigen are generated in vivo via an alternative antigen-presentation pathway.

Authors:  J Liversidge; R Dawson; A D Dick; J V Forrester
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

4.  Activation of OX40 prolongs and exacerbates autoimmune experimental uveitis.

Authors:  Xiumei Wu; James T Rosenbaum; Grazyna Adamus; Gary L Zhang; Jie Duan; Andrew Weinberg; Zili Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

5.  Interferon-γ regulates discordant mechanisms of uveitis versus joint and axial disease in a murine model resembling spondylarthritis.

Authors:  Jelena M Kezic; Michael P Davey; Tibor T Glant; James T Rosenbaum; Holly L Rosenzweig
Journal:  Arthritis Rheum       Date:  2012-03

Review 6.  Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?

Authors:  A D Dick
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

7.  Total dose and frequency of administration critically affect success of nasal mucosal tolerance induction.

Authors:  H R Jiang; N Taylor; L Duncan; A D Dick; J V Forrester
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

8.  Modulating phenotype and cytokine production of leucocytic retinal infiltrate in experimental autoimmune uveoretinitis following intranasal tolerance induction with retinal antigens.

Authors:  B Laliotou; A D Dick
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

9.  Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis.

Authors:  D A Copland; K Hussain; S Baalasubramanian; T R Hughes; B P Morgan; H Xu; A D Dick; L B Nicholson
Journal:  Clin Exp Immunol       Date:  2009-12-04       Impact factor: 4.330

Review 10.  Ocular allergy guidelines: a practical treatment algorithm.

Authors:  Leonard Bielory
Journal:  Drugs       Date:  2002       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.